Aspirin to prevent colorectal cancer: Time to act?

The Lancet

Volumn 376, Issue 9754, 2010, Pages 1713-1714

  Benamouzig, Robert ^a   Uzzan, Bernard ^a  

^a AVICENNE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO;

CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COLORECTAL CANCER; DOSE RESPONSE; DRUG WITHDRAWAL; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HAZARD RATIO; HUMAN; NOTE; PRIORITY JOURNAL; SIGMOIDOSCOPY; SMOKING; SWEDEN; TREATMENT DURATION; UNITED KINGDOM;

EID: 78650199251     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)61509-7     Document Type: Note

References (13)

1. PM Rothwell, M Wilson, C-E Elwin Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials Lancet 2010 10.1016/S0140-6736(10)61543-7 published online Oct 22.
2. TW Meade, HC Wilkes, Y Stirling, PJ Brennan, C Kelleher, W Browne Randomized controlled trial of low dose warfarin in the primary prevention of ischaemic heart disease in men at high risk: design and pilot study Eur Heart J 9 1988 836 843
3. The SALT Collaborative Group Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events Lancet 338 1991 1345 1349
4. B Farrell, J Godwin, S Richards, C Warlow The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results J Neurol Neurosurg Psychiatry 54 1991 1044 1054
5. R Peto, R Gray, R Collins Randomised trial of prophylactic daily aspirin in British male doctors BMJ 296 1988 313 316
6. The Dutch TIA Trial Study Group A comparison of two doses of aspirin (30 mg vs 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke N Engl J Med 325 1991 1261 1266
7. E Flossmann, PM Rothwell for the British Doctors Aspirin Trial and the UK-TIA Aspirin Trial Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies Lancet 369 2007 1603 1613
8. PH Gann, JE Manson, RJ Glyn, JE Buring, CH Hennekens Low-dose aspirin and incidence of colorectal tumor in a randomized trial J Natl Cancer Inst 85 1993 1220 1224
9. NR Cook, IM Lee, JM Gaziano Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial JAMA 294 2005 47 55
10. BF Cole, RF Logan, S Halabi Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials J Natl Cancer Inst 101 2009 256 266
11. K Wallace, MV Grau, D Ahnen The association of lifestyle and dietary factors with the risk for serrated polyps of the colorectum Cancer Epidemiol Biomarkers Prev 18 2009 2310 2317
12. C Dubé, A Rostom, G Lewin The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the US Preventive Services Task Force Ann Intern Med 146 2007 365 375
13. AT Chan, S Ogino, CS Fuchs Aspirin use and survival after diagnosis of colorectal cancer JAMA 302 2009 649 658